Skip to Main Content

Author Details

G??nther Stockhammer
Medical University of Innsbruck
1990
76
31
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37707754Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.J Neurooncol2023
38024240Radiomic features define risk and are linked to DNA methylation attributes in primary CNS lymphoma.Neurooncol Adv2023
35326730MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy.Cancers (Basel)2022
35855454Do neurocognitive impairments explain the differences between brain tumor patients and their proxies when assessing the patient's IADL?Neurooncol Pract2022
35394585ADC textural features in patients with single brain metastases improve clinical risk models.Clin Exp Metastasis2022
35267049Whole brain radiotherapy combined with intrathecal liposomal cytarabine for leptomeningeal metastasis-a safety analysis and validation of the EANO-ESMO classification.Strahlenther Onkol2022
34073209Phosphorous Magnetic Resonance Spectroscopy to Detect Regional Differences of Energy and Membrane Metabolism in Naïve Glioblastoma Multiforme.Cancers (Basel)2021
33706200Perampanel in brain tumor and SMART-syndrome related epilepsy - A single institutional experience.J Neurol Sci2021
33496902Development of an EORTC questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumours: phase I-III.Qual Life Res2021
34720938Sustained Complete Remission in Multi-Relapsed Primary CNS Lymphoma Treated with Ibrutinib Monotherapy: A Case Report.Case Rep Oncol2021
34298788Phosphorous Magnetic Resonance Spectroscopy and Molecular Markers in IDH1 Wild Type Glioblastoma.Cancers (Basel)2021
32461353Encephalomyeloneuritis and arthritis after treatment with immune checkpoint inhibitors.Neurol Neuroimmunol Neuroinflamm2020
30994047Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study.Acta Oncol2019
29804266Autoimmune myelitis in a CLL patient undergoing treatment with ibrutinib.Ann Hematol2019
31435852Cerebrospinal Fluid Drug Concentrations and Clinical Outcome of Patients with Neoplastic Meningitis Treated with Liposomal Cytarabine.Eur J Drug Metab Pharmacokinet2019
30301187Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.Cancers (Basel)2018
30150718The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space.Nat Med2018
27469356Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by 18F-Fluoroethyl-l-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic.J Nucl Med2017
28154933Serious tumor seeding after brainstem biopsy and its treatment-a case report and review of the literature.Acta Neurochir (Wien)2017
28210660Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc.Neurol Neuroimmunol Neuroinflamm2017
26162042Hormone-dependent shrinkage of a sphenoid wing meningioma after pregnancy: case report.J Neurosurg2016
26822319Targeted Therapies for the Treatment of Brain Metastases in Solid Tumors.Target Oncol2016
25645636Non-convulsive status epilepticus with negative phenomena--a SMART syndrome variant.Seizure2015
24220008Polyarteritis nodosa complicating multiple myeloma - a case report and review of the literature.Clin Neuropathol2014
25038849End of life care in high-grade glioma patients in three European countries: a comparative study.J Neurooncol2014
25151506Symptoms and medication management in the end of life phase of high-grade glioma patients.J Neurooncol2014
24759867An intra-individual comparison of MRI, [18F]-FET and [18F]-FLT PET in patients with high-grade gliomas.PLoS One2014
24929753Progressive multifocal leukoencephalopathy complicating untreated chronic lymphatic leukemia: case report and review of the literature.J Clin Virol2014
24727314Progression types after antiangiogenic therapy are related to outcome in recurrent glioblastoma.Neurology2014
24311637A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).Neuro Oncol2014
24337718The end-of-life phase of high-grade glioma patients: a systematic review.Support Care Cancer2014
24253501Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry.Br J Cancer2014
23335162[18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma.Neuro Oncol2013
23788269Response to "reply to [18F]-fluoro-ethyl-L-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma" by Hutterer et al.Neuro Oncol2013
20980335Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study.Neuro Oncol2011
21622893O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma.J Nucl Med2011
21312093[Patient reported outcome monitoring using a tablet PC is suitable for measuring quality of life in patients with gliomas].Wien Med Wochenschr2011
21125399ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma.Neuroradiology2011
20150267Response of recurrent high-grade glioma to treatment with (90)Y-DOTATOC.J Nucl Med2010
20152586Implementation of computer-based quality-of-life monitoring in brain tumor outpatients in routine clinical practice.J Pain Symptom Manage2010
19814834Do neurooncological patients and their significant others agree on quality of life ratings?Health Qual Life Outcomes2009
19725960RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II study.BMC Cancer2009
18172262Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme.Clin Cancer Res2008
16944367Molecular therapies for malignant glioma.Wien Med Wochenschr2006
16794761Temozolomide for recurrent or progressive high-grade malignant glioma: results of an Austrian multicenter observational study.Wien Klin Wochenschr2006
15970584MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer.Mol Cell Proteomics2005
15015790Long-term cognitive and MRI findings in a patient with paraneoplastic limbic encephalitis.J Neurooncol2004
12734662Galanin and galanin receptors in human gliomas.Acta Neuropathol2003
12883208Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab.Transplantation2003
12622090Evoked potentials in a case of progressive multifocal leukoencephalopathy.J Neurol2003
  • 1 - 50 of 76

Recommended Authors

Nancy Wang
Massachusetts General Hospital Cancer Center, Harvard Medical School
Career Start Year 2013
Number of shared co-authors 0
Sherise D Ferguson
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Gelareh Zadeh
University of Toronto
Career Start Year 2003
Number of shared co-authors 7
Marco Skardelly
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 2002
Number of shared co-authors 3
Martin Glas
University Hospital Essen
Career Start Year 2002
Number of shared co-authors 4
Mariza Daras
University of California san francisco
Career Start Year 2001
Number of shared co-authors 0
Andrew P Morokoff
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year 2001
Number of shared co-authors 0
Naoki Shinojima
Kumamoto University Hospital
Career Start Year 2000
Number of shared co-authors 0
Ghazaleh Tabatabai
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 1998
Number of shared co-authors 11
Jaishri O Blakeley
Johns Hopkins University
Career Start Year 1998
Number of shared co-authors 1
Warren P Mason
Princess Margaret Cancer Centre
Career Start Year 1996
Number of shared co-authors 7
Tracy T Batchelor
Brigham and Women's Hospital
Career Start Year 1996
Number of shared co-authors 4
Howard A Fine
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 0
Tom Mikkelsen
Ontario Brain Institute
Career Start Year 1990
Number of shared co-authors 4
Morris D Groves
The University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 0
Johan M Kros
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1988
Number of shared co-authors 8
Marica Eoli
Fondazione IRCCS Istituto Neurologico Carlo Besta
Career Start Year 1988
Number of shared co-authors 1
Motoo Nagane
Kyorin University Faculty of Medicine
Career Start Year 1988
Number of shared co-authors 1
Michael Weller
University Hospital and University of Zurich
Career Start Year 1987
Number of shared co-authors 18
Camilo E Fadul
University of Virginia Health System
Career Start Year 1987
Number of shared co-authors 0
Ryo Nishikawa
Saitama Medical University International Medical Center
Career Start Year 1986
Number of shared co-authors 2
Caterina Giannini
Mayo Clinic
Career Start Year 1985
Number of shared co-authors 5
Robert Aiken
Rutgers Cancer Institute of New Jersey, Rutgers University
Career Start Year 1984
Number of shared co-authors 1
Gaetano Finocchiaro
IRCCS San Raffaele Scientific Institute
Career Start Year 1983
Number of shared co-authors 6
Raymond Sawaya
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Career Start Year 1979
Number of shared co-authors 0
Gregory N Fuller
MD Anderson Cancer Center
Career Start Year 1978
Number of shared co-authors 3
Wai-Kwan Alfred Yung
University of Texas M.D. Anderson Cancer Center
Career Start Year 1974
Number of shared co-authors 5
Mark Rosenblum
Henry Ford Hospital
Career Start Year 1973
Number of shared co-authors 1
David Schiff
University of Virginia School of Medicine
Career Start Year 1966
Number of shared co-authors 4
Maria Martinez-Lage
Massachusetts General Hospital
Career Start Year 1960
Number of shared co-authors 2

Collaborators

Martha Nowosielski
Medical University of Innsbruck
Co-authored papers 16
Christian F Freyschlag
Medical University of Innsbruck
Co-authored papers 9
Christine Marosi
Medical University of Vienna
Co-authored papers 9
Johannes Kerschbaumer
Medical University of Innsbruck
Co-authored papers 8
Stefan Oberndorfer
Karl Landsteiner University of Health Sciences
Co-authored papers 8
Josef Pichler
Kepler University Hospital
Co-authored papers 6
Georg Widhalm
Medical University of Vienna
Co-authored papers 6
Claudius Thom??
Medical University Innsbruck
Co-authored papers 6
Johannes Haybaeck
Institute of Pathology, Medical University of Innsbruck
Co-authored papers 6
Johanna Buchroithner
Johannes Kepler University
Co-authored papers 5
Matthias Preusser
Medical University of Vienna
Co-authored papers 5
Astrid E Grams
Medical University of Innsbruck
Co-authored papers 5
Serge Weis
Kepler University Hospital, Johannes Kepler University
Co-authored papers 4
Franz Payer
Medical University of Graz
Co-authored papers 4
Gord von Campe
Medical University of Graz
Co-authored papers 4
Adelheid Woehrer
Medical University of Vienna
Co-authored papers 4
Patrizia Moser
Medical University of Innsbruck
Co-authored papers 4
Johannes A Hainfellner
Medical University of Vienna
Co-authored papers 4
Waltraud Kleindienst
Paracelsus Medical University Salzburg
Co-authored papers 3
Martin Stultschnig
State Hospital Klagenfurt
Co-authored papers 3
Franz Marhold
Karl Landsteiner University of Health Sciences
Co-authored papers 3
Karin Dieckmann
Medical University of Vienna
Co-authored papers 3
Barbara Kiesel
Medical University of Vienna
Co-authored papers 3
Tanisa Brandner-Kokalj
Institute of Pathology, State Hospital Klagenfurt
Co-authored papers 3
Eugen Trinka
Christian Doppler University Hospital, Paracelsus Medical University
Co-authored papers 3
Thomas Czech
Co-authored papers 2
Irene Slavc
Co-authored papers 2
Julia Furtner
Medical University of Vienna
Co-authored papers 2
Thomas Roetzer
Medical University of Vienna
Co-authored papers 2
Johanna Klughammer
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Co-authored papers 2
Release 1.2